871348-68-4

Upstream product

• 23130-89-4 C₁₉H₂₂N₂ 
• 871351-29-0 1-(3-chloro-1-phenylpropyl)-1H-indole 
• 74-89-5 methylamine 
• 5554-64-3 N,N-dimethyl-3-hydroxy-3-phenylpropylamine 
• 496-15-1 1-indoline 
• 915953-59-2 N-[3-(2,3-dihydro-1H-indol-1-yl)-3-phenylpropyl]-N,N-dimethylamine 

Relevant academic research and scientific papers

Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines

Compounds with a combination of norepinephrine and serotonin reuptake inhibition have been approved in the US and Europe for a number of indications, including major depressive disorder and pain disorders such as diabetic neuropathy and fibromyalgia. Efforts to design selective norepinephrine reuptake inhibitors based on SAR from the aryloxypropanamine series of monoamine reuptake inhibitors have led to the identification of a potent new class of dual acting norepinephrine and serotonin reuptake inhibitors, namely the 3-(1H-indol-1-yl)-3-arylpropan-1-amines.

3-AMINO-1-ARYLPROPYL INDOLES AS MONOAMINE REUPTAKE INHIBITOR

Compounds of formula I: or pharmaceutically acceptable salts thereof, wherein p, Ar, R1, R2, R3, Ra, Rb, Rc, Rd and Re are defined herein, pharmaceutical compositions containing them and methods of using them for the preparation of medicaments for treating depression or anxiety.